CAR T-cell trial offers promising second-line therapy for B-cell lymphoma

October 17, 2018 Providence News Team

Patients who have relapsed or failed first-line treatment for aggressive forms of B-cell non-Hodgkin lymphoma may qualify to receive a promising CAR T-cell therapy in a new clinical trial at Providence Cancer Institute:

Study: Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy (TRANSCEND-NHL-006) for B-cell non-Hodgkin lymphoma

JCAR017 is an investigational CAR T-cell therapy that modifies a patient’s own T-cells to express proteins called CARs (chimeric antigen receptors), which help T-cells recognize tumor cells and go after them. A Phase I study of JCAR017 in people with aggressive forms of B-cell lymphoma found that it provided “a durable reduction or eradication of cancer,” including complete cancer eradication in just over half of the patients. Read more in Lymphoma News Today.

CAR T-cell therapy is a major research priority for the Earle A. Chiles Research Institute, a division of Providence Cancer Institute in the Robert W. Franz Cancer Center. Read more about JCAR017 in Immuno-Oncology News, and find out more about adoptive T-cell therapy research at Providence.

Providence is one of only two centers in the United States currently participating in this clinical trial. For more information or to enroll a patient, call our Clinical Research office at 503-215-2614. Call us early for consideration, before the patient receives a salvage therapy or stem cell transplant.

See more studies
New research studies are added frequently. Please visit our website to see all studies in all cancer types currently open at Providence Cancer Institute.

Enter content here

About the Author

The Providence News Team brings you the updates to keep you informed about what's happening across the organizational ecosystem. From partnerships to new doctor announcements, we are committed to keeping you informed.
More Content by Providence News Team

Welcome to your journey for creating a healthier you

CAR T-cell trial offers promising second-line therapy for B-cell lymphoma

About the Author

Previous Article

Next Article

CAR T-cell trial offers promising second-line therapy for B-cell lymphoma

About the Author

Previous Article

Next Article

Most Recent Articles

Thanks to cardiovascular and cardiopulmonary advancements at Providence St. Joseph Hospital, Humboldt County residents with heart failure can now receive “big city” care close to home.

First dual kidney pancreas transplant at St Joseph Hospital

Nationally recognized for high quality stroke and heart failure care

Providence Little Company of Mary Medical Centers are proud to be recognized by the American Heart Association for excellence in stroke and diabetes care.

Providence Holy Cross has received the American Heart Association’s 2025 Get With The Guidelines® Stroke Gold Plus quality achievement award for its commitment to stroke and diabetes care.

PCSTMC has received the American Heart Association’s 2025 Get With The Guidelines® Stroke Gold Plus quality achievement award for its commitment to stroke and diabetes care.

A new portable X-ray machine is now calling Providence Redwood Memorial Hospital home, thanks to the generous support of community donors.

The American Heart Association has presented Get With The Guidelines Stroke 2025 Gold Plus awards to all three Providence hospital in the San Fernando Valley.

Thanks to a donation from Providence Queen of the Valley Foundation residents in remote Lake Berryessa now have access to a life-saving AED unit.

A phase III clinical trial for people with HR+ HER2- breast cancer aims to extend survival and improve patients’ quality of life.

For 81-year-old Peggy Cook, the answer to whether she would lose her hair to chemotherapy was "no," thanks to being Providence St. Joseph Hospital Eureka’s first Amma Cold Cap patient.

Donna Jordan’s heartfelt artwork celebrates the beauty of life’s journey in the Women’s Pavilion.

To fully understand just how far Valencia Little has come, it is important to understand where she began.

Back pain is among the most common and debilitating conditions, capable of hindering our mobility, disrupting our daily activities and diminishing our quality of life.

The hospital was among 16 organizations celebrated for transforming healthcare delivery across Partnership Health Plan’s 24-county service region.

ncy medical care in the community.” Queen of the Valley Medical Center’s level III trauma center and emergency department will remain open 24/7/365 throughout the renovations.

Explore how a caregiver found support and solace from her colleagues at Providence Cedars-Sinai Tarzana Medical Center during her father's battle with leukemia.

https://www.youtube.com/watch?v=BtIJsq7J--w

Providence Alaska Children’s Hospital formally dedicated the Panda Cares Center of Hope during a celebration event on Friday, June 20.

Providence Saint Joseph Medical Center in Burbank, Calif., has earned its second Magnet® recognition, a prestigious honor bestowed by the American Nurses Credentialing Center.